|Bid||0.00 x 373700|
|Ask||0.00 x 1281100|
|Day's Range||83.25 - 84.20|
|52 Week Range||67.80 - 85.40|
|PE Ratio (TTM)||30.41|
|Earnings Date||Jan 23, 2018 - Jan 29, 2018|
|Forward Dividend & Yield||2.73 (3.17%)|
|1y Target Est||N/A|
The last time Novartis AG hired a new chief, the drugmaker went with a guy who spent years at companies that make bleach and ketchup. This time around, the Swiss company chose someone with a deep understanding ...
U.S. regulators approved a revolutionary new cancer treatment from Novartis AG on Wednesday, the first in a group of coming therapies that offer breakthrough cures for dire cases as well as stratospheric ...
Novartis AG began testing a new anti-malaria pill in Africa, advancing development of an alternative to its most effective treatment that billionaire philanthropist Bill Gates said risked losing potency....